Addison Advisors LLC Has $39,000 Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Addison Advisors LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 420 shares of the exchange traded fund’s stock after selling 150 shares during the quarter. Addison Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $39,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Avoro Capital Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of SPDR S&P Biotech ETF by 30.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after acquiring an additional 15,794 shares in the last quarter. Finally, Mirae Asset Securities USA Inc. bought a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $55,626,000.

SPDR S&P Biotech ETF Trading Down 1.6 %

Shares of NYSEARCA XBI opened at $96.52 on Friday. The stock has a fifty day simple moving average of $97.74 and a two-hundred day simple moving average of $93.80. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The firm has a market cap of $7.36 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.